Abstract | BACKGROUND: METHODS: For 107 CF patients (73 children, and 34 adults) serum SP-D and SP-D Met11Thr genotype were available. Leukocyte count was obtained for a subset of patients. Lung function was measured as forced expiratory volume in one second (FEV-1). RESULTS: Serum SP-D was increased in CF patients compared to healthy controls, positively correlated to leukocyte count, and negatively correlated to FEV-1. We found no correlation between SP-D Met11Thr genotype and FEV-1, and we found corresponding genotype frequencies in CF patients and in healthy controls. CONCLUSION: Serum SP-D in CF patients was increased in parallel with leukocyte count and with reduced FEV-1 and may constitute an alternative biomarker for lung disease, in the clinical setting and in research.
|
Authors | Hanne Vebert Olesen, Uffe Holmskov, Peter Oluf Schiøtz, Grith Lykke Sørensen |
Journal | Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
(J Cyst Fibros)
Vol. 9
Issue 4
Pg. 257-62
(Jul 2010)
ISSN: 1873-5010 [Electronic] Netherlands |
PMID | 20457545
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved. |
Chemical References |
- Biomarkers
- Pulmonary Surfactant-Associated Protein D
|
Topics |
- Adolescent
- Adult
- Aged
- Biomarkers
(blood)
- Case-Control Studies
- Child
- Cystic Fibrosis
(blood, physiopathology)
- Female
- Forced Expiratory Volume
- Humans
- Leukocyte Count
- Male
- Middle Aged
- Polymorphism, Single Nucleotide
- Pulmonary Surfactant-Associated Protein D
(blood, genetics)
- Young Adult
|